0000899243-18-007648.txt : 20180315
0000899243-18-007648.hdr.sgml : 20180315
20180315185354
ACCESSION NUMBER: 0000899243-18-007648
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180313
FILED AS OF DATE: 20180315
DATE AS OF CHANGE: 20180315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kuwahara Jon
CENTRAL INDEX KEY: 0001664784
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 18693771
MAIL ADDRESS:
STREET 1: 21250 HAWTHORNE BOULEVARD
STREET 2: SUITE 800
CITY: TORRANCE
STATE: CA
ZIP: 90503
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 949-238-8090
MAIL ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
FORMER COMPANY:
FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070622
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-13
0
0001404281
Novus Therapeutics, Inc.
NVUS
0001664784
Kuwahara Jon
C/O NOVUS THERAPEUTICS, INC.
19900 MACARTHUR BLVD., SUITE 550
IRVINE
CA
92612
0
1
0
0
See Remarks
Common Stock
2018-03-13
4
A
0
11250
0.00
A
11250
D
Stock Option (Right to Buy)
4.83
2018-03-13
4
A
0
12000
0.00
A
2028-03-13
Common Stock
12000
12000
D
This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date.
This option represents a right to purchase a total of 12,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 13, 2019, with the remaining 9,000 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Senior Vice President of Finance and Administration
/s/ Ryan A. Murr, as attorney-in-fact for Jon Kuwahara
2018-03-15